Review of preclinical data of pf-07304814 and its active metabolite derivatives against sars-cov-2 infection

HIGHLIGHTS

• who: . and colleagues from the Stanford University, United States have published the research work: Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection, in the Journal: (JOURNAL)
• what: In this review, the authors focus on the preclinical data of PF-07304814 and its active metabolite derivatives to hopefully provide knowledge for researchers to study SARS-CoV-2 infection.
• future: More research on this topic is needed. due to its poor solubility and bioavailability. More models such as a mouse model of SARS-CoV-2 MA10 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.